VIGNATELLI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 5.401
AS - Asia 3.694
EU - Europa 2.694
AF - Africa 212
Continente sconosciuto - Info sul continente non disponibili 208
SA - Sud America 202
OC - Oceania 7
Totale 12.418
Nazione #
US - Stati Uniti d'America 5.261
SG - Singapore 1.015
CN - Cina 903
VN - Vietnam 894
GB - Regno Unito 631
IT - Italia 510
DE - Germania 326
SE - Svezia 301
HK - Hong Kong 239
UA - Ucraina 183
IN - India 165
FR - Francia 157
BR - Brasile 137
RU - Federazione Russa 127
BD - Bangladesh 125
KR - Corea 113
NL - Olanda 91
IE - Irlanda 90
FI - Finlandia 80
TG - Togo 80
CA - Canada 76
JP - Giappone 66
ZA - Sudafrica 45
CI - Costa d'Avorio 32
EE - Estonia 28
BE - Belgio 27
CH - Svizzera 27
ES - Italia 26
SC - Seychelles 26
AR - Argentina 24
PK - Pakistan 23
MX - Messico 22
PH - Filippine 22
TH - Thailandia 19
BG - Bulgaria 16
CO - Colombia 16
ID - Indonesia 15
AT - Austria 14
PL - Polonia 14
JO - Giordania 12
UZ - Uzbekistan 12
TW - Taiwan 11
CR - Costa Rica 10
RO - Romania 10
GR - Grecia 9
IQ - Iraq 9
JM - Giamaica 8
LT - Lituania 8
TR - Turchia 8
SA - Arabia Saudita 7
EC - Ecuador 6
HN - Honduras 6
TN - Tunisia 6
VE - Venezuela 6
CL - Cile 5
IR - Iran 5
NP - Nepal 5
NZ - Nuova Zelanda 5
EG - Egitto 4
HR - Croazia 4
LB - Libano 4
MA - Marocco 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
GH - Ghana 3
NG - Nigeria 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 12.201
Città #
Singapore 730
Ashburn 619
Southend 505
Chandler 319
San Jose 282
Ann Arbor 252
Fairfield 252
Hefei 248
Santa Clara 231
Ho Chi Minh City 225
Hong Kong 221
Hanoi 202
Dallas 198
Council Bluffs 154
Jacksonville 134
Houston 133
Los Angeles 131
Woodbridge 130
Wilmington 125
New York 118
Seattle 111
Boardman 107
Princeton 107
Seoul 98
Cambridge 96
Beijing 91
Dublin 88
Bologna 86
Lomé 80
Helsinki 68
Dong Ket 63
Tokyo 63
Lauterbourg 55
Milan 45
Padova 45
Westminster 44
Berlin 38
Chicago 38
Phoenix 38
Turin 36
Redmond 35
Jinan 34
Nanjing 33
São Paulo 33
Abidjan 32
Haiphong 32
Da Nang 31
Buffalo 30
Denver 30
Orem 30
Bengaluru 29
Brussels 27
Rome 27
San Francisco 27
Saint Petersburg 26
Bern 24
Brooklyn 24
London 23
Montreal 23
Shenyang 23
Atlanta 21
Medford 21
Toronto 21
Redondo Beach 19
Hebei 17
Mülheim 17
Redwood City 17
Tianjin 17
San Diego 16
Sofia 16
Yubileyny 15
Des Moines 14
Mahé 14
Boston 13
Johannesburg 13
Lahore 13
Shanghai 13
Frankfurt am Main 12
Guangzhou 12
Las Vegas 12
Munich 12
Nanchang 12
Naples 12
Zhengzhou 12
Amman 11
Norwalk 11
Verona 11
Amsterdam 10
Can Tho 10
Changsha 10
Jiaxing 10
Nha Trang 10
Washington 10
Chengdu 9
Hải Dương 9
Lappeenranta 9
Madrid 9
Nuremberg 9
Olalla 9
Vienna 9
Totale 7.696
Nome #
Daytime sleepiness and neural cardiac modulation in sleep-related breathing disorders. 972
The Arousal Disorders Questionnaire: a new and effective screening tool for confusional arousals, Sleepwalking and Sleep Terrors in epilepsy and sleep disorders units 345
Dysphagia in multiple system atrophy consensus statement on diagnosis, prognosis and treatment 275
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 267
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. 252
Community-onset pediatric status epilepticus: Barriers to care and outcomes in a real-world setting 239
Health-related quality of life in clinically isolated syndrome and risk of conversion to multiple sclerosis 237
Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. 219
Magnetic resonance imaging scoring system of the lower limbs in adult patients with suspected idiopathic inflammatory myopathy 217
Mesial temporal lobe epilepsy (MTLE): prognostic factors 217
Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1 211
Memoria semantica durante il sonno REM di pazienti narcolettici 210
Medico-legal assessment of disability in narcolepsy: an interobserver reliability study 204
Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study 203
Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS 201
Sex disparities in clinical features and burden of narcolepsy type 1 199
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: A prospective study 199
Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management 199
Patient-centred estimation of multimorbidity in chronic disease populations: a novel approach integrating global burden of disease metrics and healthcare administrative data 198
Quality of life, eating and mood disorders in menstrual migraine: a case-control study 196
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 195
Antidepressant drugs for narcolepsy 194
Parasomnias versus epilepsy: common grounds and a need to change the approach to the problem. 194
Movement disorders in sleep: guidelines for differentiating epileptic from non-epileptic motor phenomena arising from sleep. 194
Prognostic factors in patients with mesial temporal lobe epilepsy 193
Semantic memory during REM sleep of narcoleptic patients 187
Diagnosis of Nocturnal Frontal Lobe Seizures: The Diagnostic Accuracy of Clinical History. 187
Protocols of a diagnostic study and a randomized controlled non-inferiority trial comparing televisits vs standard in-person outpatient visits for narcolepsy diagnosis and care: TElemedicine for NARcolepsy (TENAR) 185
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. 181
Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment 181
Work productivity and activity impairment in patients with narcolepsy type 1 179
Memoria procedurale e dichiarativa durante il sonno di pazienti narcolettici 178
Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. 174
Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults 174
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 174
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 171
Antidepressant drugs for narcolepsy. 169
Sleep and time course of consolidation of visual discrimination skills in patients with narcolepsy-cataplexy. 165
Interobserver reliability of ICSD-R minimal diagnostic criteria for the parasomnias. 165
Health-related quality of life in patients with Nocturnal Frontal Lobe Epilepsy. 162
Frequency of Parasomnias in patients with Nocturnal Frontal Lobe Epilepsy (NFLE) and their relatives. 161
Interobserver reliability of video recording in the diagnosis of nocturnal frontal lobe seizures. 160
Interobserver reliability of video-polysomnographic diagnosis of Nocturnal Frontal Lobe seizures. 159
Epidemiology of status epilepticus in a rural area of northern Italy: a 2-year population-based study 159
A pragmatic approach to test the reliaility af permanent impairment classification 157
Heart Rate Variability as a Tool for Seizure Prediction: A Scoping Review 156
Nocturnal baroreflex sensitivity and heart rate variability are markers of excessive daytime sleepiness in sleep related breathing disorders. 154
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 153
Resilience and its correlates in patients with narcolepsy type 1 149
L'analisi dell'accordo fra osservatori e delle fonti di variabilità come strumento per il miglioramento della qualità in medicina legale 149
Diagnostic accuracy of clinical history in the diagnosis of Nocturnal Frontal Lobe seizures. 147
Nocturnal frontal lobe epilepsy and arousal disorders: chance association or common mechanisms? 142
Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey. 141
Restless legs syndrome and periodic limb movement disorder 138
Impaired cortical and autonomic arousal during sleep in multiple system atrophy. 136
Sleep-related hypermotor epilepsy: Long-term outcome in a large cohort 132
Valutazione medico-legale del danno biologico nella persona anziana. I risultati della consensus conference multidisciplinare 127
Reliability of narcolepsy assessment for disability benefit 116
In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients 111
Interobserver reliability in the assessment of disablement in patients with narcolepsy 106
Interrater reliability as quantitative end-point for legal medicine in work ability assessment: a lesson from an epidemiological study applied to a neurological disease 98
Reliability and diagnostic accuracy of home video recording in differentiating sleep-related hypermotor epilepsy from disorders of arousal 92
null 85
Epidemiological survey on status epilepticus in Bologna and Lugo di Romagna: Incidence, prognosis and treatment 80
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 73
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 71
Quality of life and disability in pure autonomic failure: More than a prodromal synucleinopathy 70
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 55
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 46
Corrigendum to “Quantitative dried blood spot microsampling for therapeutic drug monitoring of -antiseizure medications by design of experiment and UHPLC-MS/MS” 13
Post-Ictal aphasia in focal Epilepsy: Speech-language pathologist Perspectives and insights 10
Real-world evaluation of capillary microsampling for drug monitoring of anti-seizure medications 9
null 1
Totale 12.418
Categoria #
all - tutte 31.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022876 0 0 0 73 87 62 29 66 37 121 233 168
2022/20231.240 127 220 78 160 78 98 29 63 178 41 99 69
2023/2024429 45 64 27 60 29 78 16 31 10 32 13 24
2024/20251.442 55 211 118 101 259 70 87 32 15 97 76 321
2025/20265.077 460 412 375 297 453 202 385 110 753 319 1.028 283
2026/2027646 118 142 362 24 0 0 0 0 0 0 0 0
Totale 12.418